Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The conference is scheduled to take place from January 13-16, 2025, in San Francisco, California.

The company's management team, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will be conducting one-on-one meetings during the conference. This participation represents an important opportunity for Lifecore to engage with healthcare industry stakeholders and investors.

CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 43^rd Annual J.P. Morgan Healthcare Conference. The conference will take place January 13-16, 2025, in San Francisco, California.

Details regarding Lifecore’s participation are as follows:

• 43^rd Annual J.P. Morgan Healthcare Conference
  Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings
  Conference Dates: January 13-16, 2025
  Location: San Francisco, California

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

FAQ

When is Lifecore Biomedical (LFCR) participating in the J.P. Morgan Healthcare Conference 2025?

Lifecore Biomedical will participate in the conference from January 13-16, 2025, in San Francisco, California.

Which Lifecore Biomedical (LFCR) executives are attending the 2025 J.P. Morgan Healthcare Conference?

Paul Josephs, CEO, and Ryan Lake, CFO, will represent Lifecore Biomedical at the conference.

What type of meetings will Lifecore Biomedical (LFCR) conduct at the J.P. Morgan Healthcare Conference 2025?

Lifecore management will participate in one-on-one meetings during the conference.

Where is the 43rd J.P. Morgan Healthcare Conference featuring Lifecore Biomedical (LFCR) being held?

The conference is being held in San Francisco, California.